Periodontal Therapeutics Market to Reach Worth $580.5 Mn by 2025
- Jason Schwartz
- Sep 11, 2017
According to the latest report published by Credence Research, Inc. “Periodontal Therapeutics Market – (Treatment Type – Systematic Antibiotics: Doxycycline, Minocycline, Metronidazole, and Others; Local Antibiotics: Arestin, Chlorhexidine, and Others): Market Growth, Future Prospects and Competitive Analysis, 2017-2025,” the market was valued at US$ 259.5 Mn in 2016, and is expected to reach US$ 580.5 Mn by 2025, expanding at a CAGR of 9.2% from 2017 to 2025.
For the full report, Periodontal Therapeutics Market: Market Growth, Future Prospects and Competitive Analysis, 2017-2025 click here.
Other Blogs
-
- Jason Schwartz
- Feb 10, 2017
Gum disease is one of the most prevalent, yet rarely-discussed diseases, in fact it’s 2.5 times more common than diabetes.-64.7 million adults have periodontal disease-OR 1 out of every 2 people-Th
-
- Jason Schwartz
- Jan 3, 2017
According to the Academy of General Dentistry (AGD), emotional anxiety could affect dental health.
-
- Jason Schwartz
- Dec 15, 2016
Though gum disease has long been associated with rheumatoid arthritis, there has been no solid evidence connecting the two. Until now, that is.
